Gi/o-coupled α1B adrenoceptor in osteoblast

British Journal of Pharmacology

Volumn 168, Issue 5, 2013, Pages 1230-1239

  Kodama, D ^a   Togari, A ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

cell proliferation; heterotrimeric G protein; osteoblast; potassium channels; sympathetic nervous system

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ALPHA 1B ADRENERGIC RECEPTOR; BROXURIDINE; CALCIUM ION; CESIUM CHLORIDE; CHLOROETHYLCLONIDINE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NORADRENALIN; PERTUSSIS TOXIN; POTASSIUM CHANNEL; TETRAZOLIUM; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; CALCIUM CELL LEVEL; CELL ASSAY; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NORADRENERGIC SYSTEM; OSTEOBLAST; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; REGULATORY MECHANISM; CELL LINE; DRUG EFFECT; PHYSIOLOGY;

ADRENERGIC ALPHA-AGONISTS; CELL LINE; CELL PROLIFERATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; NOREPINEPHRINE; OSTEOBLASTS; POTASSIUM CHANNELS; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 84874238220     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12000     Document Type: Article

References (56)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Arai M, Nagasawa T, Koshihara Y, Yamamoto S, Togari A, (2003). Effects of beta-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells. Biochim Biophys Acta 1640: 137-142.
3. Battaglia G, Fornai F, Busceti CL, Lembo G, Nicoletti F, De Blasi A, (2003). Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicity. J Neurochem 86: 413-421.
4. Bonnet N, Gadois C, McCloskey E, Lemineur G, Lespessailles E, Courteix D, et al. (2007). Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture. Bone 40: 1209-1216.
5. Bonnet N, Benhamou CL, Malaval L, Goncalves C, Vico L, Eder V, et al. (2008). Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions. J Cell Physiol 217: 819-827.
6. Burg ED, Remillard CV, Yuan JX, (2008). Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications. Br J Pharmacol 153 (Suppl. 1): S99-S111.
7. Casey LM, Pistner AR, Belmonte SL, Migdalovich D, Stolpnik O, Nwakanma FE, et al. (2010). Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure. Circ Res 107: 532-539.
8. Cherruau M, Facchinetti P, Baroukh B, Saffar JL, (1999). Chemical sympathectomy impairs bone resorption in rats: a role for the sympathetic system on bone metabolism. Bone 25: 545-551.
9. Cordeaux Y, Ijzerman AP, Hill SJ, (2004). Coupling of the human A1 adenosine receptor to different heterotrimeric G proteins: evidence for agonist-specific G protein activation. Br J Pharmacol 143: 705-714.
10. Davies MG, Huynh TT, Hagen PO, (1999). Functional characterization of alpha1-adrenergic receptors in experimental vein grafts. J Surg Res 84: 40-45.
11. Docherty JR, (2010). Subtypes of functional alpha1-adrenoceptor. Cell Mol Life Sci 67: 405-417.
12. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, et al. (2005). Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434: 514-520.
13. Filippov AK, Fernández-Fernández JM, Marsh SJ, Simon J, Barnard EA, Brown DA, (2004). Activation and inhibition of neuronal G protein-gated inwardly rectifying K(+) channels by P2Y nucleotide receptors. Mol Pharmacol 66: 468-477.
14. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G, (2005). The molecular clock mediates leptin-regulated bone formation. Cell 122: 803-815.
15. Gazi L, Nickolls SA, Strange PG, (2003). Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity. Br J Pharmacol 138: 775-786.
16. Hasseldine AR, Harper EA, Black JW, (2003). Cardiac-specific overexpression of human beta2 adrenoceptors in mice exposes coupling to both Gs and Gi proteins. Br J Pharmacol 138: 1358-1366.
17. He JY, Jiang LS, Dai LY, (2011). The roles of the sympathetic nervous system in osteoporotic diseases: a review of experimental and clinical studies. Ageing Res Rev 10: 253-263.
18. Henney NC, Li B, Elford C, Reviriego P, Campbell AK, Wann KT, et al. (2009). A large-conductance (BK) potassium channel subtype affects both growth and mineralization of human osteoblasts. Am J Physiol Cell Physiol 297: C1397-C1408.
19. Hernandez L, Park KH, Cai SQ, Qin L, Partridge N, Sesti F, (2007). The antiproliferative role of ERG K+ channels in rat osteoblastic cells. Cell Biochem Biophys 47: 199-208.
20. Hirukawa K, Muraki K, Ohya S, Imaizumi Y, Togari A, (2008). Electrophysiological properties of a novel Ca(2+)-activated K(+) channel expressed in human osteoblasts. Calcif Tissue Int 83: 222-229.
21. Huang HH, Brennan TC, Muir MM, Mason RS, (2009). Functional alpha1- and beta2-adrenergic receptors in human osteoblasts. J Cell Physiol 220: 267-275.
22. Hughes S, Magnay J, Foreman M, Publicover SJ, Dobson JP, El Haj AJ, (2006). Expression of the mechanosensitive 2PK+ channel TREK-1 in human osteoblasts. J Cell Physiol 206: 738-748.
23. Inoue R, Okada T, Onoue H, Hara Y, Shimizu S, Naitoh S, et al. (2001). The transient receptor potential protein homologue TRP6 is the essential component of vascular alpha(1)-adrenoceptor-activated Ca(2+)-permeable cation channel. Circ Res 88: 325-332.
24. Jang SS, Park J, Hur SW, Hong YH, Hur J, Chae JH, et al. (2011). Endothelial progenitor cells functionally express inward rectifier potassium channels. Am J Physiol Cell Physiol 301: C150-C161.
25. Katz A, Wu D, Simon MI, (1992). Subunits beta gamma of heterotrimeric G protein activate beta 2 isoform of phospholipase C. Nature 360: 686-689.
26. Kim Y, Park MK, Uhm DY, Shin J, Chung S, (2005). Modulation of delayed rectifier potassium channels by alpha1-adrenergic activation via protein kinase C zeta and p62 in PC12 cells. Neurosci Lett 387: 43-48.
27. Kodama D, Togari A, (2010). Modulation of potassium channels via the α1B-adrenergic receptor in human osteoblasts. Neurosci Lett 485: 102-106.
28. Komoto S, Kondo H, Fukuta O, Togari A, (2012). Comparison of β-adrenergic and glucocorticoid signaling on clock gene and osteoblast-related gene expressions in human osteoblast. Chronobiol Int 29: 66-74.
29. Kondo H, Togari A, (2011). Continuous treatment with a low-dose β-agonist reduces bone mass by increasing bone resorption without suppressing bone formation. Calcif Tissue Int 88: 23-32.
30. Koshihara Y, Kawamura M, Oda H, Higaki S, (1987). In vitro calcification in human osteoblastic cell line derived from periosteum. Biochem Biophys Res Commun 145: 651-657.
31. Lee US, Cui J, (2010). BK channel activation: structural and functional insights. Trends Neurosci 33: 415-423.
32. Liebau S, Pröpper C, Böckers T, Lehmann-Horn F, Storch A, Grissmer S, et al. (2006). Selective blockage of Kv1.3 and Kv3.1 channels increases neural progenitor cell proliferation. J Neurochem 99: 426-437.
33. Lüscher C, Slesinger PA, (2010). Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat Rev Neurosci 11: 301-315.
34. McDonald SJ, Dooley PC, McDonald AC, Djouma E, Schuijers JA, Ward AR, et al. (2011). α(1) adrenergic receptor agonist, phenylephrine, actively contracts early rat rib fracture callus ex vivo. J Orthop Res 29: 740-745.
35. Marx SO, Kurokawa J, Reiken S, Motoike H, D'Armiento J, Marks AR, et al. (2002). Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295: 496-499.
36. Mathie A, (2007). Neuronal two-pore-domain potassium channels and their regulation by G protein-coupled receptors. J Physiol 578: 377-385.
37. Nishiura T, Abe K, (2007). Alpha1-adrenergic receptor stimulation induces the expression of receptor activator of nuclear factor kappaB ligand gene via protein kinase C and extracellular signal-regulated kinase pathways in MC3T3-E1 osteoblast-like cells. Arch Oral Biol 52: 778-785.
38. O-Uchi J, Sasaki H, Morimoto S, Kusakari Y, Shinji H, Obata T, et al. (2008). Interaction of alpha1-adrenoceptor subtypes with different G proteins induces opposite effects on cardiac L-type Ca2+ channel. Circ Res 102: 1378-1388.
39. Pardo LA, Contreras-Jurado C, Zientkowska M, Alves F, Stühmer W, (2005). Role of voltage-gated potassium channels in cancer. J Membr Biol 205: 115-124.
40. Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC, (2004). Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J Bone Miner Res 19: 19-24.
41. Patel AJ, Honoré E, (2001). Properties and modulation of mammalian 2P domain K+ channels. Trends Neurosci 24: 339-346.
42. Rivard K, Trépanier-Boulay V, Rindt H, Fiset C, (2009). Electrical remodeling in a transgenic mouse model of alpha1B-adrenergic receptor overexpression. Am J Physiol Heart Circ Physiol 296: H704-H718.
43. Sato M, Jiao Q, Honda T, Kurotani R, Toyota E, Okumura S, et al. (2009). Activator of G protein signaling 8 (AGS8) is required for hypoxia-induced apoptosis of cardiomyocytes: role of G betagamma and connexin 43 (CX43). J Biol Chem 284: 31431-31440.
44. Sato T, Arai M, Goto S, Togari A, (2010). Effects of propranolol on bone metabolism in spontaneously hypertensive rats. J Pharmacol Exp Ther 334: 99-105.
45. Souverein PC, Van Staa TP, Egberts AC, De la Rosette JJ, Cooper C, Leufkens HG, (2003). Use of alpha-blockers and the risk of hip/femur fractures. J Intern Med 254: 548-554.
46. Suzuki A, Palmer G, Bonjour JP, Caverzasio J, (1998). Catecholamines stimulate the proliferation and alkaline phosphatase activity of MC3T3-E1 osteoblast-like cells. Bone 23: 197-203.
47. Suzuki A, Palmer G, Bonjour JP, Caverzasio J, (2001). Stimulation of sodium-dependent inorganic phosphate transport by activation of Gi/o-protein-coupled receptors by epinephrine in MC3T3-E1 osteoblast-like cells. Bone 28: 589-594.
48. Takeuchi T, Tsuboi T, Arai M, Togari A, (2001). Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. Biochem Pharmacol 61: 579-586.
49. Togari A, (2002). Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 58: 77-84.
50. Togari A, Arai M, (2008). Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption. J Pharmacol Sci 106: 542-546.
51. Togari A, Arai M, Mizutani S, Mizutani S, Koshihara Y, Nagatsu T, (1997). Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci Lett 233: 125-128.
52. bg and Kv1.3 channels mediate potassium efflux in the early phase of apoptosis in Jurkat T lymphocytes. Am J Physiol Cell Physiol 297: C1544-C1533.
53. Wenzel-Seifert K, Seifert R, (2000). Molecular analysis of beta(2)-adrenoceptor coupling to G(s)-, G(i)-, and G(q)-proteins. Mol Pharmacol 58: 954-966.
54. Xiang Y, Rybin VO, Steinberg SF, Kobilka B, (2002). Caveolar localization dictates physiologic signaling of beta 2-adrenoceptors in neonatal cardiac myocytes. J Biol Chem 277: 34280-34286.
55. Yang S, Nguyen ND, Center JR Jr, Eisman JA, Nguyen TV, (2011). Association between beta-blocker use and fracture risk: the Dubbo Osteoporosis Epidemiology Study. Bone 48: 451-455.
56. Zhou XB, Wulfsen I, Lutz S, Utku E, Sausbier U, Ruth P, et al. (2008). M2 muscarinic receptors induce airway smooth muscle activation via a dual, Gbetagamma-mediated inhibition of large conductance Ca2+-activated K+ channel activity. J Biol Chem 283: 21036-21044.